{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:40:31Z","timestamp":1783942831120,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,15]]},"DOI":"10.7759\/cureus.82285","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:02:42Z","timestamp":1744711362000},"source":"Crossref","is-referenced-by-count":3,"title":["Atrial Fibrillation in Geriatric Patients: A Cross-Sectional Analysis of Risk Factors and Disease Patterns"],"prefix":"10.7759","author":[{"given":"Elizabeth Caroline","family":"Palaparthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya Aishwarya","family":"Titty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagyashree K","family":"Bhuyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Gudimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna Sai Kumar Reddy","family":"Nandyala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Vivekanandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2014.01.004","article-title":"Global burden of atrial fibrillation in developed and developing nations","volume":"9","author":"Chugh SS","year":"2014","unstructured":"Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart. 2014, 9:113-9. 10.1016\/j.gheart.2014.01.004","journal-title":"Glob Heart"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin EJ","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998, 98:946-52. 10.1161\/01.cir.98.10.946","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"285","author":"Go AS","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001, 285:2370-5. 10.1001\/jama.285.18.2370","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty BM","year":"1997","unstructured":"Psaty BM, Manolio TA, Kuller LH, et al.. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997, 96:2455-61. 10.1161\/01.cir.96.7.2455","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation","volume":"128","author":"Boriani G","year":"2015","unstructured":"Boriani G, Laroche C, Diemberger I, et al.. Asymptomatic atrial fibrillation. Am J Med. 2015, 128:509-18. 10.1016\/j.amjmed.2014.11.026","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030583","article-title":"Assessment of remote heart rhythm sampling using the Alivecor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study","volume":"136","author":"Halcox JP","year":"2017","unstructured":"Halcox JP, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, Gravenor MB. Assessment of remote heart rhythm sampling using the Alivecor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation. 2017, 136:1784-94. 10.1161\/CIRCULATIONAHA.117.030583","journal-title":"Circulation"},{"key":"ref8","article-title":"Clinical features and outcomes of atrial fibrillation patients aged <60 years","volume":"94","author":"Patton KK","year":"2004","unstructured":"Patton KK, Zacks ES, Chang JY, Shea MA, Ruskin JN, Estes NA. Clinical features and outcomes of atrial fibrillation patients aged &lt;60 years. Am J Cardiol. 2004, 94:802-5.","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.03.003","article-title":"Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications","volume":"13","author":"Siontis KC","year":"2016","unstructured":"Siontis KC, Gersh BJ, Killian JM, et al.. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm. 2016, 13:1418-24. 10.1016\/j.hrthm.2016.03.003","journal-title":"Heart Rhythm"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin EJ","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994, 271:840-4.","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley RR","year":"2011","unstructured":"Huxley RR, Lopez FL, Folsom AR, et al.. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011, 123:1501-8. 10.1161\/CIRCULATIONAHA.110.009035","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.02.050","article-title":"Diabetes mellitus as a risk for atrial fibrillation","volume":"105","author":"Movahed MR","year":"2005","unstructured":"Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus as a risk for atrial fibrillation. Int J Cardiol. 2005, 105:315-8. 10.1016\/j.ijcard.2005.02.050","journal-title":"Int J Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.071","article-title":"Pericardial fat is independently associated with human atrial fibrillation","volume":"56","author":"Al Chekakie MO","year":"2010","unstructured":"Al Chekakie MO, Welles CC, Metoyer R, et al.. Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol. 2010, 56:784-8. 10.1016\/j.jacc.2010.03.071","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.123992","article-title":"Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease","volume":"127","author":"Bansal N","year":"2013","unstructured":"Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013, 127:569-74. 10.1161\/CIRCULATIONAHA.112.123992","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"29","author":"Zimmerman D","year":"2014","unstructured":"Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant. 2014, 29:2152. 10.1093\/ndt\/gfs416","journal-title":"Nephrol Dial Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf PA","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991, 22:983-8. 10.1161\/01.str.22.8.983","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026693","article-title":"Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration","volume":"135","author":"Freedman B","year":"2017","unstructured":"Freedman B, Camm J, Calkins H, et al.. Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation. 2017, 135:1851-67. 10.1161\/CIRCULATIONAHA.116.026693","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak RK","year":"2015","unstructured":"Pathak RK, Middeldorp ME, Meredith M, et al.. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015, 65:2159-69. 10.1016\/j.jacc.2015.03.002","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed HS","year":"2013","unstructured":"Abed HS, Wittert GA, Leong DP, et al.. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013, 310:2050-60. 10.1001\/jama.2013.280521","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.032","article-title":"J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study","volume":"61","author":"Nielsen JB","year":"2013","unstructured":"Nielsen JB, Graff C, Pietersen A, et al.. J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study. J Am Coll Cardiol. 2013, 61:2557-64. 10.1016\/j.jacc.2013.03.032","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353631-atrial-fibrillation-in-geriatric-patients-a-cross-sectional-analysis-of-risk-factors-and-disease-patterns","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:02:43Z","timestamp":1744711363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353631-atrial-fibrillation-in-geriatric-patients-a-cross-sectional-analysis-of-risk-factors-and-disease-patterns"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.82285","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}